TP53 and renal pelvis/ureter urothelial carcinoma: Accordingly, TP53 signaling pathway was significantly more common in our UTUC cohort; whereas, RTK/RAS and PI3K signaling pathways were more prevalent in the MSKCC-UTUC cohort (Figure 8B).